This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Illumina (ILMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Illumina (ILMN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
HRMY vs. ILMN: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
HRMY vs. ILMN: Which Stock Is the Better Value Option?
Agenus (AGEN) Surges 19.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
Agenus (AGEN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Illumina Stock May Benefit From New Agreement to Acquire SomaLogic
by Zacks Equity Research
ILMN jumps 2.9% after striking a $350M deal to acquire SomaLogic and boost its fast-growing multiomics strategy.
SGIOY or ZTS: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SGIOY vs. ZTS: Which Stock Is the Better Value Option?
GOOS vs. IDEXY: Which Stock Is the Better Value Option?
by Zacks Equity Research
GOOS vs. IDEXY: Which Stock Is the Better Value Option?
HMY or FNV: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HMY vs. FNV: Which Stock Is the Better Value Option?
FTRE vs. ILMN: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
FTRE vs. ILMN: Which Stock Is the Better Value Option?
ADRNY vs. CLX: Which Stock Is the Better Value Option?
by Zacks Equity Research
ADRNY vs. CLX: Which Stock Is the Better Value Option?